Masashi Nibuya
Overview
Explore the profile of Masashi Nibuya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Isogaya Y, Suzuki C, Hoshina S, Nibuya M, Suzuki E
PCN Rep
. 2024 Jun;
1(2):e20.
PMID: 38868644
Aim: Previous research shows that telephone consultation is useful in suicide prevention, substance use disorder, and other mental illnesses. However, no study has been conducted with a specific focus on...
2.
Nibuya M, Kezuka D, Kanno Y, Wakamatsu S, Suzuki E
J Psychiatr Res
. 2023 Dec;
170:207-216.
PMID: 38157668
Some immune molecules including neurite outgrowth inhibitor (Nogo) ligands and their receptor（Nogo receptor-1: NgR1）are expressed at the neuronal synaptic sites. Paired immunoglobulin-like receptor B (PirB) is another Nogo receptor that...
3.
Sakurada K, Nibuya M, Yamada K, Nakagawa S, Suzuki E
Case Rep Psychiatry
. 2021 Sep;
2021:8470045.
PMID: 34540303
. Kleptomania is an impulse-control disorder that results in an irresistible urge to steal. It is often observed as a comorbidity in patients undergoing pharmacological treatment for Parkinson's disease. Recurrent...
4.
Isogaya Y, Suzuki C, Hoshina S, Yamada K, Nibuya M, Suzuki E
Psychiatry Clin Neurosci
. 2020 Oct;
75(1):30-31.
PMID: 33030222
No abstract available.
5.
Usui K, Yamada K, Okada K, Ouchi R, Nibuya M, Takahashi A, et al.
Psychiatry Clin Neurosci
. 2020 Sep;
75(1):27-28.
PMID: 32951331
No abstract available.
6.
Okada K, Yamada K, Usui K, Ouchi R, Nibuya M, Takahashi A, et al.
Psychiatry Clin Neurosci
. 2020 Sep;
74(11):629-631.
PMID: 32909640
No abstract available.
7.
Tanichi M, Shimizu K, Enomoto S, Koga M, Toda H, Nagamine M, et al.
Eur J Pharmacol
. 2019 Oct;
865:172751.
PMID: 31654623
Post-traumatic stress disorder (PTSD) is a trauma- and stressor-related disorder, characterized by bi-directional symptomatic manifestations of increase in both hyperarousal/hypervigilance and numbing/avoidance. In our previous reports, we have proposed an...
8.
Sakurada K, Kozaru T, Yamada K, Nibuya M, Nagata K, Suzuki E
Neuropsychiatr Dis Treat
. 2018 May;
14:1139-1142.
PMID: 29765217
A 73-year-old man, exhibiting psychomotor excitement after traumatic brain injury, developed allergic cutaneous eruptions and hepatic inflammation that did not resolve after the cessation of carbamazepine (CBZ). Fusing maculopapular erythema...
9.
Enomoto S, Shimizu K, Nibuya M, Suzuki E, Nagata K, Kondo T
Neurosci Lett
. 2017 Sep;
660:45-50.
PMID: 28890399
Electroconvulsive therapy (ECT) is still the most effective strategy to treat severe and drug-resistant depressive disorders. Electroconvulsive seizure (ECS), which induces neuroplastic structural alterations and resilient behavioral changes in experimental...
10.
Aoki R, Kobayashi N, Suzuki G, Kuratsune H, Shimada K, Oka N, et al.
Biochem Biophys Res Commun
. 2016 Jul;
478(1):424-430.
PMID: 27396623
Fatigue reduces productivity and is a risk factor for lifestyle diseases and mental disorders. Everyone experiences physiological fatigue and recovers with rest. Pathological fatigue, however, greatly reduces quality of life...